{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T11:15:47Z","timestamp":1720610147967},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T00:00:00Z","timestamp":1536969600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s12149-018-1302-8","type":"journal-article","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T08:19:56Z","timestamp":1537085996000},"page":"47-54","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of 18F-Choline PET\/CT and MRI functional parameters in prostate cancer"],"prefix":"10.1007","volume":"33","author":[{"given":"Xavier","family":"Palard-Novello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Beuzit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Gambarota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Le Jeune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Garin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Yves","family":"Sala\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Devillers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sol\u00e8ne","family":"Querellou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Bourguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Saint-Jalmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,15]]},"reference":[{"issue":"6","key":"1302_CR1","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/ijc.29894","volume":"138","author":"CK Zhou","year":"2016","unstructured":"Zhou CK, Check DP, Lortet-Tieulent J, Laversanne M, Jemal A, Ferlay J, et al. Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group. Int J Cancer. 2016;138(6):1388\u2013400.","journal-title":"Int J Cancer"},{"issue":"1","key":"1302_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13550-017-0269-0","volume":"7","author":"JD Schaefferkoetter","year":"2017","unstructured":"Schaefferkoetter JD, Wang Z, Stephenson MC, Roy S, Conti M, Eriksson L, et al. Quantitative 18F-fluorocholine positron emission tomography for prostate cancer: correlation between kinetic parameters and Gleason scoring. EJNMMI Res. 2017;7(1):25.","journal-title":"EJNMMI Res"},{"issue":"4","key":"1302_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12149-018-1246-z","volume":"32","author":"X Palard-Novello","year":"2018","unstructured":"Palard-Novello X, Blin AL, Bourhis D, Garin E, Salaun PY, Devillers A, et al. Comparison of choline influx from dynamic (18)F-Choline PET\/CT and clinicopathological parameters in prostate cancer initial assessment. Ann Nucl Med. 2018;32(4):281\u201387.","journal-title":"Ann Nucl Med"},{"issue":"1","key":"1302_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1148\/radiol.2017162321","volume":"284","author":"T Tamada","year":"2017","unstructured":"Tamada T, Prabhu V, Li J, Babb JS, Taneja SS, Rosenkrantz AB. Prostate cancer: diffusion-weighted MR imaging for detection and assessment of aggressiveness-comparison between conventional and kurtosis models. Radiology. 2017;284(1):100\u20138.","journal-title":"Radiology"},{"issue":"3","key":"1302_CR5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1148\/radiol.13121454","volume":"267","author":"Y Peng","year":"2013","unstructured":"Peng Y, Jiang Y, Yang C, Brown JB, Antic T, Sethi I, et al. Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score\u2014a computer-aided diagnosis development study. Radiology. 2013;267(3):787\u201396.","journal-title":"Radiology"},{"issue":"6","key":"1302_CR6","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.2214\/AJR.11.6861","volume":"197","author":"A Oto","year":"2011","unstructured":"Oto A, Yang C, Kayhan A, Tretiakova M, Antic T, Schmid-Tannwald C, et al. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. AJR Am J Roentgenol. 2011;197(6):1382\u201390.","journal-title":"AJR Am J Roentgenol"},{"issue":"1078","key":"1302_CR7","doi-asserted-by":"publisher","first-page":"20170067","DOI":"10.1259\/bjr.20170067","volume":"90","author":"E Hauth","year":"2017","unstructured":"Hauth E, Halbritter D, Jaeger H, Hohmuth H, Beer M. Diagnostic value of semi-quantitative and quantitative analysis of functional parameters in multiparametric MRI of the prostate. Br J Radiol. 2017;90(1078):20170067.","journal-title":"Br J Radiol"},{"issue":"3","key":"1302_CR8","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.eururo.2013.05.045","volume":"64","author":"EK Vos","year":"2013","unstructured":"Vos EK, Litjens GJ, Kobus T, Hambrock T, Hulsbergen-van de Kaa CA, Barentsz JO, et al. Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T. Eur Urol. 2013;64(3):448\u201355.","journal-title":"Eur Urol"},{"issue":"4","key":"1302_CR9","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2214\/AJR.15.14912","volume":"206","author":"AM Hotker","year":"2016","unstructured":"Hotker AM, Mazaheri Y, Aras O, Zheng J, Moskowitz CS, Gondo T, et al. Assessment of prostate cancer aggressiveness by use of the combination of quantitative DWI and dynamic contrast-enhanced MRI. AJR Am J Roentgenol. 2016;206(4):756\u201363.","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"1302_CR10","first-page":"1065","volume":"57","author":"M Piert","year":"2016","unstructured":"Piert M, Montgomery J, Kunju LP, Siddiqui J, Rogers V, Rajendiran T, et al. 18F-Choline PET\/MRI: the additional value of PET for MRI-guided transrectal prostate biopsies. J Nucl Med Off Publ Soc Nucl Med. 2016;57(7):1065\u201370.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"1302_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1748-717X-7-14","volume":"7","author":"M Pinkawa","year":"2012","unstructured":"Pinkawa M, Piroth MD, Holy R, Klotz J, Djukic V, Corral NE, et al. Dose-escalation using intensity-modulated radiotherapy for prostate cancer\u2014evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost. Radiat Oncol. 2012;7:14.","journal-title":"Radiat Oncol"},{"issue":"12","key":"1302_CR12","first-page":"1805","volume":"42","author":"TR DeGrado","year":"2001","unstructured":"DeGrado TR, Baldwin SW, Wang S, Orr MD, Liao RP, Friedman HS, et al. Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers. J Nucl Med Off Publ Soc Nucl Med. 2001;42(12):1805\u201314.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"1","key":"1302_CR13","first-page":"92","volume":"43","author":"TR DeGrado","year":"2002","unstructured":"DeGrado TR, Reiman RE, Price DT, Wang S, Coleman RE. Pharmacokinetics and radiation dosimetry of 18F-fluorocholine. J Nucl Med Off Publ Soc Nucl Med. 2002;43(1):92\u20136.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"1","key":"1302_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2967\/jnumed.110.077941","volume":"52","author":"H Jadvar","year":"2011","unstructured":"Jadvar H. Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline. Journal of nuclear medicine: official publication. Soc Nucl Med. 2011;52(1):81\u20139.","journal-title":"Soc Nucl Med"},{"issue":"20","key":"1302_CR15","first-page":"4630","volume":"56","author":"KK Bhakoo","year":"1996","unstructured":"Bhakoo KK, Williams SR, Florian CL, Land H, Noble MD. Immortalization and transformation are associated with specific alterations in choline metabolism. Cancer Res. 1996;56(20):4630\u20135.","journal-title":"Cancer Res"},{"key":"1302_CR16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.4103\/1947-2714.100994","volume":"4","author":"A Massaro","year":"2012","unstructured":"Massaro A, Ferretti A, Secchiero C, Cittadin S, Milan E, Tamiso L, et al. Optimising 18F-choline PET\/CT acquisition protocol in prostate cancer patients. N Am J Med Sci. 2012;4:416\u201320.","journal-title":"N Am J Med Sci"},{"key":"1302_CR17","first-page":"215650","volume":"2014","author":"S Chondrogiannis","year":"2014","unstructured":"Chondrogiannis S, Marzola MC, Grassetto G, Maffione AM, Rampin L, Veronese E, et al. New acquisition protocol of 18F-choline PET\/CT in prostate cancer patients: review of the literature about methodology and proposal of standardization. Biomed Res Int. 2014;2014:215650.","journal-title":"Biomed Res Int"},{"issue":"1","key":"1302_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13550-018-0410-8","volume":"8","author":"X Palard-Novello","year":"2018","unstructured":"Palard-Novello X, Blin AL, Le Jeune F, Garin E, Salaun PY, Devillers A, et al. Optimization of temporal sampling for (18)F-choline uptake quantification in prostate cancer assessment. EJNMMI Res. 2018;8(1):49.","journal-title":"EJNMMI Res"},{"issue":"3","key":"1302_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S","volume":"10","author":"PS Tofts","year":"1999","unstructured":"Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging JMRI. 1999;10(3):223\u201332.","journal-title":"J Magn Reson Imaging JMRI"},{"issue":"11","key":"1302_CR20","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1118\/1.2794176","volume":"34","author":"G Glatting","year":"2007","unstructured":"Glatting G, Kletting P, Reske SN, Hohl K, Ring C. Choosing the optimal fit function: comparison of the Akaike information criterion and the F-test. Med Phys. 2007;34(11):4285\u201392.","journal-title":"Med Phys"},{"issue":"Suppl 2","key":"1302_CR21","first-page":"43S","volume":"49","author":"C Plathow","year":"2008","unstructured":"Plathow C, Weber WA. Tumor cell metabolism imaging. J Nucl Med Off Publ Soc Nucl Med. 2008;49(Suppl 2):43S\u201363S.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"5","key":"1302_CR22","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/153537020623100503","volume":"231","author":"V Michel","year":"2006","unstructured":"Michel V, Yuan Z, Ramsubir S, Bakovic M. Choline transport for phospholipid synthesis. Exp Biol Med. 2006;231(5):490\u2013504.","journal-title":"Exp Biol Med"},{"issue":"9","key":"1302_CR23","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1007\/s00259-014-2786-7","volume":"41","author":"T Perrot de","year":"2014","unstructured":"de Perrot T, Rager O, Scheffler M, Lord M, Pusztaszeri M, Iselin C, et al. Potential of hybrid (1)(8)F-fluorocholine PET\/MRI for prostate cancer imaging. Eur J Nucl Med Mol Imaging. 2014;41(9):1744\u201355.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"1302_CR24","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.2214\/AJR.13.11304","volume":"201","author":"R Rakheja","year":"2013","unstructured":"Rakheja R, Chandarana H, DeMello L, Jackson K, Geppert C, Faul D, et al. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET\/MRI. AJR American J Roentgenol. 2013;201(5):1115\u20139.","journal-title":"AJR American J Roentgenol"},{"issue":"11","key":"1302_CR25","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1055\/s-0033-1350110","volume":"185","author":"P Heusch","year":"2013","unstructured":"Heusch P, Buchbender C, Kohler J, Nensa F, Beiderwellen K, Kuhl H, et al. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET\/MRI in non-small cell lung cancer (NSCLC) lesions: initial results. RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen der Nuklearmedizin. 2013;185(11):1056\u201362.","journal-title":"RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen der Nuklearmedizin"},{"issue":"7","key":"1302_CR26","first-page":"1053","volume":"54","author":"BH Byun","year":"2013","unstructured":"Byun BH, Kong CB, Lim I, Choi CW, Song WS, Cho WH, et al. Combination of 18F-FDG PET\/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma. J Nucl Med Off Publ Soc Nucl Med. 2013;54(7):1053\u20139.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"8","key":"1302_CR27","first-page":"e355-e36","volume":"42","author":"SK Vadi","year":"2017","unstructured":"Vadi SK, Singh B, Basher RK, Watts A, Sood AK, Lal A, et al. 18F-fluorocholine PET\/CT complementing the role of dynamic contrast-enhanced MRI for providing comprehensive diagnostic workup in prostate cancer patients with suspected relapse following radical prostatectomy. Clin Nucl Med. 2017;42(8):e355-e36.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"1302_CR28","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2214\/AJR.17.18567","volume":"210","author":"U Metser","year":"2018","unstructured":"Metser U, Berlin A, Halankar J, Murphy G, Jhaveri KS, Ghai S, et al. 18F-fluorocholine PET whole-body MRI in the staging of high-risk prostate cancer. AJR Am J Roentgenol. 2018;210(3):635\u201340.","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"1302_CR29","first-page":"365","volume":"56","author":"EE Verwer","year":"2015","unstructured":"Verwer EE, Oprea-Lager DE, van den Eertwegh AJ, van Moorselaar RJ, Windhorst AD, Schwarte LA, et al. Quantification of 18F-fluorocholine kinetics in patients with prostate cancer. J Nucl Med Off Publ Soc Nucl Med. 2015;56(3):365\u201371.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"2","key":"1302_CR30","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1148\/radiol.2016160220","volume":"282","author":"JY Choi","year":"2017","unstructured":"Choi JY, Yang J, Noworolski SM, Behr S, Chang AJ, Simko JP, et al. 18f fluorocholine dynamic time-of-flight PET\/MR imaging in patients with newly diagnosed intermediate- to high-risk prostate cancer: initial clinical-pathologic comparisons. Radiology. 2017;282(2):429\u201336.","journal-title":"Radiology"},{"key":"1302_CR31","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.210088","author":"M Grkovski","year":"2018","unstructured":"Grkovski M, Gharzeddine K, Sawan P, Schoder H, Michaud L, Weber WA, et al. 11C-choline pharmacokinetics in recurrent prostate cancer. J Nucl Med. 2018. https:\/\/doi.org\/10.2967\/jnumed.118.210088 .","journal-title":"J Nucl Med."},{"issue":"3","key":"1302_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/1450-1147.136734","volume":"12","author":"M Takesh","year":"2013","unstructured":"Takesh M. Kinetic modeling application to (18)F-fluoroethylcholine positron emission tomography in patients with primary and recurrent prostate cancer using two-tissue compartmental model. World J Nucl Med. 2013;12(3):101\u201310.","journal-title":"World J Nucl Med"},{"issue":"20","key":"1302_CR33","doi-asserted-by":"publisher","first-page":"9369","DOI":"10.1158\/0008-5472.CAN-05-1146","volume":"65","author":"E Iorio","year":"2005","unstructured":"Iorio E, Mezzanzanica D, Alberti P, Spadaro F, Ramoni C, D\u2019Ascenzo S, et al. Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res. 2005;65(20):9369\u201376.","journal-title":"Cancer Res"},{"issue":"5","key":"1302_CR34","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.clinimag.2015.04.020","volume":"39","author":"E Cho","year":"2015","unstructured":"Cho E, Chung DJ, Yeo DM, Sohn D, Son Y, Kim T, et al. Optimal cut-off value of perfusion parameters for diagnosing prostate cancer and for assessing aggressiveness associated with Gleason score. Clin Imaging. 2015;39(5):834\u201340.","journal-title":"Clin Imaging"},{"issue":"4 Suppl","key":"1302_CR35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1353\/hpu.2014.0005","volume":"24","author":"H Xiao","year":"2013","unstructured":"Xiao H, Tan F, Goovaerts P, Adunlin G, Ali A, Huang Y, et al. Factors associated with time-to-treatment of prostate cancer in Florida. J Health Care Poor Underserved. 2013;24(4 Suppl):132\u201346.","journal-title":"J Health Care Poor Underserved"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-018-1302-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-018-1302-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-018-1302-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T10:55:37Z","timestamp":1720608937000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-018-1302-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,15]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["1302"],"URL":"https:\/\/doi.org\/10.1007\/s12149-018-1302-8","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,15]]},"assertion":[{"value":"21 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study (retrospective), the local ethics committee waived the requirement for informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}